Pilot Evaluation of the Influence of ABT450r, Ombitasvir, Dasabuvir +/- Ribavirin HCV Therapy on Insulin Resistance and Lipid Profile
Phase of Trial: Phase IV
Latest Information Update: 29 Sep 2017
At a glance
- Drugs Dasabuvir (Primary) ; Ombitasvir/paritaprevir/ritonavir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms 3D
- 20 Sep 2017 Planned End Date changed from 1 Mar 2017 to 1 Dec 2018.
- 20 Sep 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2018.
- 14 Apr 2016 New trial record